"The Cancer Center at Beth Israel Deaconess Medical Center (BIDMC) offers world-class cancer care, diagnosis and treatment, provided in the personalized and compassionate manner for which our institution is famous. Our goal is to provide the best cancer care to our patients, while tirelessly pursuing a cure."

During the past decade, Beth Israel Deaconess Med Ctr; Hem/Onc conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Beth Israel Deaconess Med Ctr; Hem/Onc" are "Non-Small Cell Lung Cancer" (3 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Beth Israel Deaconess Med Ctr; Hem/Onc" in a lesser frequency.

Most popular intervention types in "Beth Israel Deaconess Med Ctr; Hem/Onc" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Crizotinib" (1 trials) and "Daratumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beth Israel Deaconess Med Ctr; Hem/Onc" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Beth Israel Deaconess Med Ctr; Hem/Onc". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Beth Israel Deaconess Med Ctr; Hem/Onc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beth Israel Deaconess Med Ctr; Hem/Onc, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".